HCA Healthcare, Inc. (LON:0J1R)
London
· Delayed Price · Currency is GBP · Price in USD HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of GBP 66.09 billion. The enterprise value is 101.59 billion.
| Market Cap | 66.09B |
| Enterprise Value | 101.59B |
Important Dates
The next estimated earnings date is Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
| Current Share Class | 240.57M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -5.86% |
| Shares Change (QoQ) | -2.30% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 168.13M |
Valuation Ratios
The trailing PE ratio is 14.78 and the forward PE ratio is 14.49.
| PE Ratio | 14.78 |
| Forward PE | 14.49 |
| PS Ratio | 1.19 |
| PB Ratio | -194.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.03, with an EV/FCF ratio of 26.53.
| EV / Earnings | 22.71 |
| EV / Sales | 1.93 |
| EV / EBITDA | 9.03 |
| EV / EBIT | 12.71 |
| EV / FCF | 26.53 |
Financial Position
The company has a current ratio of 1.19
| Current Ratio | 1.19 |
| Quick Ratio | 0.90 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.04 |
| Debt / FCF | 9.38 |
| Interest Coverage | 5.17 |
Financial Efficiency
Return on equity (ROE) is 1,605.77% and return on invested capital (ROIC) is 15.16%.
| Return on Equity (ROE) | 1,605.77% |
| Return on Assets (ROA) | 11.61% |
| Return on Invested Capital (ROIC) | 15.16% |
| Return on Capital Employed (ROCE) | 23.48% |
| Revenue Per Employee | 204,450 |
| Profits Per Employee | 16,505 |
| Employee Count | 316,000 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 22.89 |
Taxes
In the past 12 months, HCA Healthcare has paid 1.49 billion in taxes.
| Income Tax | 1.49B |
| Effective Tax Rate | 22.35% |
Stock Price Statistics
The stock price has increased by +10.58% in the last 52 weeks. The beta is 1.50, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | +10.58% |
| 50-Day Moving Average | 361.98 |
| 200-Day Moving Average | 348.47 |
| Relative Strength Index (RSI) | 54.02 |
| Average Volume (20 Days) | 129 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.98 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of GBP 55.41 billion and earned 4.47 billion in profits. Earnings per share was 17.39.
| Revenue | 55.41B |
| Gross Profit | 22.66B |
| Operating Income | 8.39B |
| Pretax Income | 6.66B |
| Net Income | 4.47B |
| EBITDA | 11.01B |
| EBIT | 8.39B |
| Earnings Per Share (EPS) | 17.39 |
Balance Sheet
The company has 903.25 million in cash and 35.94 billion in debt, giving a net cash position of -35.04 billion.
| Cash & Cash Equivalents | 903.25M |
| Total Debt | 35.94B |
| Net Cash | -35.04B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -339.01M |
| Book Value Per Share | -11.21 |
| Working Capital | 2.03B |
Cash Flow
In the last 12 months, operating cash flow was 7.50 billion and capital expenditures -3.67 billion, giving a free cash flow of 3.83 billion.
| Operating Cash Flow | 7.50B |
| Capital Expenditures | -3.67B |
| Free Cash Flow | 3.83B |
| FCF Per Share | n/a |
Margins
Gross margin is 40.90%, with operating and profit margins of 15.15% and 8.07%.
| Gross Margin | 40.90% |
| Operating Margin | 15.15% |
| Pretax Margin | 12.02% |
| Profit Margin | 8.07% |
| EBITDA Margin | 19.86% |
| EBIT Margin | 15.15% |
| FCF Margin | 6.91% |
Dividends & Yields
This stock pays an annual dividend of 2.11, which amounts to a dividend yield of 0.56%.
| Dividend Per Share | 2.11 |
| Dividend Yield | 0.56% |
| Dividend Growth (YoY) | 5.31% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 11.85% |
| Buyback Yield | 5.86% |
| Shareholder Yield | 6.42% |
| Earnings Yield | 6.77% |
| FCF Yield | 5.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.65 |
| Piotroski F-Score | 7 |